SeaBeLife
SeaBeLife is a biotech company developing drugs to block cellular necrosis, focusing on a new therapeutic approach for geographic atrophy, an advanced form of age-related macular degeneration. Their SeaBeEYE project centers around a molecule blocking necroptosis and ferroptosis, responsible for photoreceptor cell death, aiming for clinical trials by Q1 2026.
Buy Funded Startups lists
Funding Round: Grant
Funding Amount: €1.5M
Date: 22-Apr-2024
Investors: French government
Markets: Biotech, Ophthalmology
HQ: Roscoff, Bretagne, France
Founded: 2019
Website: https://www.seabelife.com
LinkedIn: https://www.linkedin.com/company/seabelife-biotech
Facebook: https://www.facebook.com/seabelife.bio
Crunchbase: https://www.crunchbase.com/organization/seabelife
Leave a Comment
Comments
No comments yet.